Artigos de revistas sobre o tema "Targeted nanotherapy"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Targeted nanotherapy".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Kim, Gloria J., e Shuming Nie. "Targeted cancer nanotherapy". Materials Today 8, n.º 8 (agosto de 2005): 28–33. http://dx.doi.org/10.1016/s1369-7021(05)71034-8.
Texto completo da fonteMathew, Anila, Toru Maekawa e D. Sakthikumar. "Aptamers in Targeted Nanotherapy". Current Topics in Medicinal Chemistry 15, n.º 12 (17 de abril de 2015): 1102–14. http://dx.doi.org/10.2174/1568026615666150413153525.
Texto completo da fonteZhu, Peng, Carl Atkinson, Suraj Dixit, Qi Cheng, Danh Tran, Kunal Patel, Yu-Lin Jiang et al. "Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo". RSC Advances 8, n.º 46 (2018): 25909–19. http://dx.doi.org/10.1039/c8ra01555d.
Texto completo da fonteCrintea, Andreea, Anne-Marie Constantin, Alexandru C. Motofelea, Carmen-Bianca Crivii, Maria A. Velescu, Răzvan L. Coșeriu, Tamás Ilyés, Alexandra M. Crăciun e Ciprian N. Silaghi. "Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer". Journal of Functional Biomaterials 14, n.º 9 (9 de setembro de 2023): 466. http://dx.doi.org/10.3390/jfb14090466.
Texto completo da fonteNarayanan, Sreeja, N. S. Binulal, Ullas Mony, Koyakutty Manzoor, Shantikumar Nair e Deepthy Menon. "Folate targeted polymeric ‘green’ nanotherapy for cancer". Nanotechnology 21, n.º 28 (28 de junho de 2010): 285107. http://dx.doi.org/10.1088/0957-4484/21/28/285107.
Texto completo da fonteKatsogiannou, M., L. Peng, C. V. Catapano e P. Rocchi. "Active-Targeted Nanotherapy Strategies for Prostate Cancer". Current Cancer Drug Targets 11, n.º 8 (1 de outubro de 2011): 954–65. http://dx.doi.org/10.2174/156800911797264770.
Texto completo da fonteMetcalfe, Su M., e Tarek M. Fahmy. "Targeted nanotherapy for induction of therapeutic immune responses". Trends in Molecular Medicine 18, n.º 2 (fevereiro de 2012): 72–80. http://dx.doi.org/10.1016/j.molmed.2011.11.002.
Texto completo da fonteHu, Xiankang, e Jianxiang Zhang. "Yeast capsules for targeted delivery: the future of nanotherapy?" Nanomedicine 12, n.º 9 (maio de 2017): 955–57. http://dx.doi.org/10.2217/nnm-2017-0059.
Texto completo da fonteRapoport, N. Ya, K. H. Nam, Z. Gao e A. Kennedy. "Application of ultrasound for targeted nanotherapy of malignant tumors". Acoustical Physics 55, n.º 4-5 (18 de julho de 2009): 594–601. http://dx.doi.org/10.1134/s1063771009040162.
Texto completo da fonteSoodgupta, Deepti, Dipanjan Pan, Grace Hu, Angana Senpan, Xiaoxia Yang, Katherine N. Weilbaecher, Edward V. Prochownik, Gregory M. Lanza e Michael H. Tomasson. "Preclinical Development Of a Nanomedicne Approach For Multiple Myeloma Targeting The Myc Oncoprotein". Blood 122, n.º 21 (15 de novembro de 2013): 4228. http://dx.doi.org/10.1182/blood.v122.21.4228.4228.
Texto completo da fonteKoneru, Tejaswi, Eva McCord, Shreya Pawar, Katyayani Tatiparti, Samaresh Sau e Arun K. Iyer. "Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas". ACS Omega 6, n.º 13 (22 de março de 2021): 8727–33. http://dx.doi.org/10.1021/acsomega.0c05848.
Texto completo da fonteKeen, Judith C. "A step towards a new targeted nanotherapy for pancreatic cancer". Cancer Biology & Therapy 7, n.º 10 (outubro de 2008): 1591–92. http://dx.doi.org/10.4161/cbt.7.10.6758.
Texto completo da fonteZhou, Xia-Qing, Ya-Ping Li e Shuang-Suo Dang. "Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy". World Journal of Hepatology 16, n.º 2 (27 de fevereiro de 2024): 164–76. http://dx.doi.org/10.4254/wjh.v16.i2.164.
Texto completo da fonteMarcelo, Gonçalo A., David Montpeyó, Joana Galhano, Ramón Martínez-Máñez, José Luis Capelo-Martínez, Julia Lorenzo, Carlos Lodeiro e Elisabete Oliveira. "Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer". International Journal of Molecular Sciences 24, n.º 7 (1 de abril de 2023): 6612. http://dx.doi.org/10.3390/ijms24076612.
Texto completo da fonteAwad, Noor A., Nahi Y. Yassen, Amer T. Tawfeeq e Kismat M. Turki. "Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line". Journal of the Faculty of Medicine Baghdad 57, n.º 4 (3 de janeiro de 2016): 320–24. http://dx.doi.org/10.32007/jfacmedbagdad.574399.
Texto completo da fonteAsik, Elif, Yeliz Akpinar, Ayse Caner, Nermin Kahraman, Tulin Guray, Murvet Volkan, Constance Albarracin, Apar Pataer, Banu Arun e Bulent Ozpolat. "EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppressesBRCA1-mutated breast cancer". Nanomedicine 14, n.º 17 (setembro de 2019): 2315–38. http://dx.doi.org/10.2217/nnm-2019-0132.
Texto completo da fonteZhou, Hui-fang, Happy W. Chan, Samuel A. Wickline, Gregory M. Lanza e Christine T. N. Pham. "α v β 3 –Targeted nanotherapy suppresses inflammatory arthritis in mice". FASEB Journal 23, n.º 9 (17 de abril de 2009): 2978–85. http://dx.doi.org/10.1096/fj.09-129874.
Texto completo da fonteJournaux, Justine, M. Bejko, P. Clerc, Y. Al Yaman, C. Bousquet, S. Mornet, O. Sandre e V. Gigoux. "Nanotherapy of pancreatic adenocarcinoma by targeted magnetic hyperthermia: efficacy and mechanisms." Pancreatology 22 (novembro de 2022): e74-e75. http://dx.doi.org/10.1016/j.pan.2022.06.193.
Texto completo da fonteHaque, Sakib, Kiri Cook, Gaurav Sahay e Conroy Sun. "RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer". Pharmaceutics 13, n.º 10 (15 de outubro de 2021): 1694. http://dx.doi.org/10.3390/pharmaceutics13101694.
Texto completo da fonteKara, Goknur, Pinar Atalay Dundar, Nermin Kahraman, Emir Baki Denkbas e Bulent Ozpolat. "Abstract 461: Dual-kinase targeted miRNA nanotherapy for the treatment of triple-negative breast cancer". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 461. http://dx.doi.org/10.1158/1538-7445.am2024-461.
Texto completo da fonteSajjadi, Mohaddeseh, Mahmoud Nasrollahzadeh, Babak Jaleh, Ghazaleh Jamalipour Soufi e Siavash Iravani. "Carbon-based nanomaterials for targeted cancer nanotherapy: recent trends and future prospects". Journal of Drug Targeting 29, n.º 7 (18 de fevereiro de 2021): 716–41. http://dx.doi.org/10.1080/1061186x.2021.1886301.
Texto completo da fonteKAJIMOTO, Kazuaki. "Adipose Vasculature Targeted Nanotherapy Leads to a Novel Strategy of Obesity Treatment". Oleoscience 15, n.º 3 (2015): 107–14. http://dx.doi.org/10.5650/oleoscience.15.107.
Texto completo da fonteKomizu, Yuji, Sayuri Nakata, Koichi Goto, Yoko Matsumoto e Ryuichi Ueoka. "Membrane-Targeted Nanotherapy with Hybrid Liposomes for Tumor Cells Leading to Apoptosis". ACS Medicinal Chemistry Letters 2, n.º 4 (13 de janeiro de 2011): 275–79. http://dx.doi.org/10.1021/ml100269t.
Texto completo da fonteAgrahari, Vivek. "The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches". Neural Regeneration Research 12, n.º 2 (2017): 197. http://dx.doi.org/10.4103/1673-5374.200796.
Texto completo da fonteDelie, Florence, Patrick Petignat e Marie Cohen. "GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78". Targeted Oncology 8, n.º 4 (23 de outubro de 2012): 225–30. http://dx.doi.org/10.1007/s11523-012-0234-9.
Texto completo da fonteNguyen, Dai Hai, Jung Seok Lee, Jin Woo Bae, Jong Hoon Choi, Yunki Lee, Joo Young Son e Ki Dong Park. "Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice". International Journal of Pharmaceutics 495, n.º 1 (novembro de 2015): 329–35. http://dx.doi.org/10.1016/j.ijpharm.2015.08.083.
Texto completo da fontePan, Dipanjan, Benjamin Kim, Grace Hu, Deepti Sood Gupta, Angana Senpan, Xiaoxia Yang, Anne Schmieder et al. "A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy". Nanomedicine 10, n.º 2 (janeiro de 2015): 241–51. http://dx.doi.org/10.2217/nnm.14.101.
Texto completo da fonteRoss, Michael H., Alison K. Esser, Gregory C. Fox, Anne H. Schmieder, Xiaoxia Yang, Grace Hu, Dipanjan Pan et al. "Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases". Cancer Research 77, n.º 22 (30 de agosto de 2017): 6299–312. http://dx.doi.org/10.1158/0008-5472.can-17-1225.
Texto completo da fonteWang, Xiaoxuan, Fangxuan Li, Jialu Zhang, Lu Guo, Mengmeng Shang, Xiao Sun, Shan Xiao et al. "A combination of PD-L1-targeted IL-15 mRNA nanotherapy and ultrasound-targeted microbubble destruction for tumor immunotherapy". Journal of Controlled Release 367 (março de 2024): 45–60. http://dx.doi.org/10.1016/j.jconrel.2024.01.039.
Texto completo da fonteZhang, Qixiong, Fuzhong Zhang, Shanshan Li, Renfeng Liu, Taotao Jin, Yin Dou, Zhenhua Zhou e Jianxiang Zhang. "A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment". Theranostics 9, n.º 13 (2019): 3732–53. http://dx.doi.org/10.7150/thno.34377.
Texto completo da fontePuligujja, Pavan, Mariluz Araínga, Prasanta Dash, Diana Palandri, R. Lee Mosley, Santhi Gorantla, Larisa Poluektova, JoEllyn McMillan e Howard E. Gendelman. "Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice". Antiviral Research 120 (agosto de 2015): 85–88. http://dx.doi.org/10.1016/j.antiviral.2015.05.009.
Texto completo da fonteNg, Thomas S. C., David Wert, Hargun Sohi, Daniel Procissi, David Colcher, Andrew A. Raubitschek e Russell E. Jacobs. "Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101". Clinical Cancer Research 19, n.º 9 (26 de março de 2013): 2518–27. http://dx.doi.org/10.1158/1078-0432.ccr-12-2738.
Texto completo da fonteSong, Xinhao, Mengjuan Lin, Tian Fang, Jiahao Gong, Junqi Wang, Shasha Gao, Xiaolin Xu et al. "Maduramicin-guided nanotherapy: A polymeric micelles for targeted drug delivery in canine mammary tumors". Biomedicine & Pharmacotherapy 170 (janeiro de 2024): 116062. http://dx.doi.org/10.1016/j.biopha.2023.116062.
Texto completo da fonteJiang, Quzi, Luodan Yu e Yu Chen. "Engineering Self-Assembled Nanomedicines Composed of Clinically Approved Medicines for Enhanced Tumor Nanotherapy". Nanomaterials 13, n.º 18 (5 de setembro de 2023): 2499. http://dx.doi.org/10.3390/nano13182499.
Texto completo da fonteGolzar, Hossein, Fatemeh Yazdian, Mohadeseh Hashemi, Meisam Omidi, Dorsa Mohammadrezaei, Hamid Rashedi, Masoumeh Farahani, Nazanin Ghasemi, Javad Shabani shayeh e Lobat Tayebi. "Optimizing the hybrid nanostructure of functionalized reduced graphene oxide/silver for highly efficient cancer nanotherapy". New Journal of Chemistry 42, n.º 15 (2018): 13157–68. http://dx.doi.org/10.1039/c8nj01764f.
Texto completo da fonteJanani, Balakarthikeyan, Mayakrishnan Vijayakumar, Kannappan Priya, Jin Hee Kim, D. S. Prabakaran, Mohammad Shahid, Sameer Al-Ghamdi et al. "EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges". Vaccines 10, n.º 4 (24 de março de 2022): 499. http://dx.doi.org/10.3390/vaccines10040499.
Texto completo da fonteLin, Mingzhen, Lili Teng, Yang Wang, Jiaxin Zhang e Xianglian Sun. "Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy". Drug Delivery 23, n.º 4 (23 de julho de 2015): 1420–25. http://dx.doi.org/10.3109/10717544.2015.1066902.
Texto completo da fonteKhan, Suliman, Majid Sharifi, Jason P. Gleghorn, Mohammad Mahdi Nejadi Babadaei, Samir Haj Bloukh, Zehra Edis, Mohammadreza Amin et al. "Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy". Journal of Controlled Release 348 (agosto de 2022): 127–47. http://dx.doi.org/10.1016/j.jconrel.2022.05.055.
Texto completo da fonteZhang, Jin. "The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis". Journal of Healthcare Engineering 2021 (26 de novembro de 2021): 1–6. http://dx.doi.org/10.1155/2021/3982158.
Texto completo da fonteGupta, Tanvi, Tilahun Ayane Debele, Yu-Feng Wei, Anish Gupta, Mohd Murtaza e Wen-Pin Su. "Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence". Cancers 14, n.º 1 (2 de janeiro de 2022): 213. http://dx.doi.org/10.3390/cancers14010213.
Texto completo da fonteMitri, Fabio Franceschini. "Advances of the Nanotechnology in Targeted Nanomedicines for Treatment of Bone Cancers and Diseases". Journal of Cancer Research Updates 10 (30 de dezembro de 2021): 32–45. http://dx.doi.org/10.30683/1929-2279.2021.10.05.
Texto completo da fonteWu, Jianrong, Zheying Meng, Agata A. Exner, Xiaojun Cai, Xue Xie, Bing Hu, Yu Chen e Yuanyi Zheng. "Biodegradable cascade nanocatalysts enable tumor-microenvironment remodeling for controllable CO release and targeted/synergistic cancer nanotherapy". Biomaterials 276 (setembro de 2021): 121001. http://dx.doi.org/10.1016/j.biomaterials.2021.121001.
Texto completo da fonteYoo, Byunghee, Amol Kavishwar, Alana Ross, Ping Wang, Doris P. Tabassum, Kornelia Polyak, Natalia Barteneva et al. "Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer". Cancer Research 75, n.º 20 (10 de setembro de 2015): 4407–15. http://dx.doi.org/10.1158/0008-5472.can-15-0888.
Texto completo da fonteBariana, Manpreet, Beilu Zhang, Jingyu Sun, Elena Cassella, Janice Rateshwar, Ming Tony Tan, Weiwei Wang et al. "Targeted Nanotherapy of Hematologic Malignancies Using Gold Nanoframework-Based Delivery of a Novel NF-Kb Inhibitor". Blood 140, Supplement 1 (15 de novembro de 2022): 6018–19. http://dx.doi.org/10.1182/blood-2022-160324.
Texto completo da fonteTrandafir, Laura M., Gianina Dodi, Otilia Frasinariu, Alina C. Luca, Lacramioara I. Butnariu, Elena Tarca e Stefana M. Moisa. "Tackling Dyslipidemia in Obesity from a Nanotechnology Perspective". Nutrients 14, n.º 18 (13 de setembro de 2022): 3774. http://dx.doi.org/10.3390/nu14183774.
Texto completo da fonteReddy, Hrushikesh, G. Jyothi, Maheshwari, D.Prasad e M.Sudhakar. "Nanoliposomes-A Review". World Journal of Pharmaceutical Sciences 10, n.º 03 (2022): 299–307. http://dx.doi.org/10.54037/wjps.2022.100308.
Texto completo da fonteSILVA, ADRIANA L. DA, RAQUEL S. SANTOS, DÉBORA G. XISTO, SILVIA DEL V. ALONSO, MARCELO M. MORALES e PATRICIA R. M. ROCCO. "Nanoparticle-based therapy for respiratory diseases". Anais da Academia Brasileira de Ciências 85, n.º 1 (5 de março de 2013): 137–46. http://dx.doi.org/10.1590/s0001-37652013005000018.
Texto completo da fonteMahajan, Supriya, Ravikumar Aalinkeel, Jessica Reynolds, Bindukumar Nair, Donald Sykes, Wing-Cheung Law, Paras Prasad e Stanley Schwartz. "Innovative nanotherapy for the treatment of the chronic skin condition, rosacea. (P3259)". Journal of Immunology 190, n.º 1_Supplement (1 de maio de 2013): 192.15. http://dx.doi.org/10.4049/jimmunol.190.supp.192.15.
Texto completo da fonteNewton, Emily R., David C. Gillis, Kui Sun, Brooke R. Dandurand, Robin Siletzky, Suvendu Biswas, Mark R. Karver, Nick D. Tsihlis, Samuel I. Stupp e Melina R. Kibbe. "Evaluation of a Targeted Drug‐Eluting Intravascular Nanotherapy to Prevent Neointimal Hyperplasia in an Atherosclerotic Rat Model". Advanced NanoBiomed Research 1, n.º 7 (3 de maio de 2021): 2000093. http://dx.doi.org/10.1002/anbr.202000093.
Texto completo da fonteHalling Folkmar Andersen, Anna, e Martin Tolstrup. "The Potential of Long-Acting, Tissue-Targeted Synthetic Nanotherapy for Delivery of Antiviral Therapy Against HIV Infection". Viruses 12, n.º 4 (7 de abril de 2020): 412. http://dx.doi.org/10.3390/v12040412.
Texto completo da fonte